文献速递腹部技术与安全US

超声脂肪分数对肝肿瘤患者肝脂肪变性的诊断效能

Diagnostic performance of ultrasound-derived fat fraction for detecting hepatic steatosis in patients with tumor-related liver disease.
PubMed 文献 · Abdom Radiol (NY) · 2026-09-02

这项前瞻性研究纳入64例拟行肝脏手术的成人患者,以术后非肿瘤肝组织病理为参考标准,评估超声衍生脂肪分数(UDFF)检测肝脂肪变性的能力。UDFF值随病理脂肪变性分级升高而增加,对检测≥1级和≥2级脂肪变性的AUC分别为0.885和0.967。UDFF可独立预测脂肪变性并提升模型判别力,具有临床应用价值。

要点

  • UDFF升高提示背景肝脂肪变性,最佳截断值4.75%对应≥1级、8.50%对应≥2级。
  • UDFF测量受肝脏组织异质性影响,肝肿瘤患者需注意取样位置避开肿瘤区域。

核心结论

  • UDFF可准确、独立地定量评估肿瘤相关肝病背景肝脂肪变性,并具有临床净获益。
  • 研究确定的4.75%和8.50%截断值可辅助术前评估与治疗计划制定。

研究设计与样本

  • 前瞻性研究,入组64例拟行肝脏手术的成人患者,术前完成UDFF评估。
  • 以术后非肿瘤肝组织病理学作为参考标准,用于验证UDFF诊断效能。
  • 采用ROC分析评价诊断效能,Youden指数确定截断值,多变量回归评估增量预测价值,决策曲线分析评估临床效用。

关键影像表现/征象

  • UDFF值随组织学脂肪变性等级升高而进行性增加(p<0.0001)。
  • UDFF为脂肪变性的独立预测因子,≥1级脂肪变性OR=1.95,≥2级脂肪变性OR=2.58。
  • UDFF显著改善模型判别力,≥1级脂肪变性ΔAUC=0.161,≥2级脂肪变性ΔAUC=0.256。

诊断标准与关键数值

  • 检测≥1级肝脂肪变性的AUC为0.885,最佳截断值UDFF为4.75%。
  • 检测≥2级肝脂肪变性的AUC为0.967,最佳截断值UDFF为8.50%。
  • 决策曲线分析显示在临床相关阈值概率范围内具有一致的净临床获益。

临床应用与阅片要点

  • 肝肿瘤患者术前可用UDFF定量评估背景肝脂肪变性,辅助术前风险分层。
  • UDFF截断值4.75%以上提示存在≥1级脂肪变性,8.50%以上提示≥2级脂肪变性。
  • 肝肿瘤组织异质性可影响UDFF测量可靠性,需选择非肿瘤区域进行测量。

局限性

  • 单中心研究,样本量为64例,研究结果的外推性可能受限。
  • 组织异质性可影响UDFF测量可靠性,可能造成测量误差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Accurate assessment of hepatic steatosis is crucial for preoperative risk stratification in patients with liver tumors. However, the diagnostic performance of the noninvasive ultrasound-derived fat fraction (UDFF) remains uncertain, where tissue heterogeneity can impair measurement reliability. Using histopathology as the reference standard, this study aimed to evaluate the ability of UDFF to detect and grade background hepatic steatosis.

METHODS: In this prospective study, 64 adults scheduled for hepatic surgery were enrolled. All patients underwent preoperative UDFF assessment, and postoperative histopathology of non-tumorous liver tissue served as the reference. Diagnostic performance, incremental predictive value, and clinical utility were evaluated using ROC analysis (Youden index for cutoff determination), multivariable regression (ΔAUC assessment), and decision curve analysis.

RESULTS: UDFF values increased progressively with histological steatosis grades (p < 0.0001). The AUCs for detecting S ≥ 1 and S ≥ 2 steatosis were 0.885 and 0.967, with corresponding optimal cutoffs of 4.75% and 8.50%. UDFF was an independent predictor of steatosis (OR = 1.95 for S ≥ 1; OR = 2.58 for S ≥ 2) and significantly improved model discrimination (ΔAUC = 0.161 and 0.256). Decision curve analysis demonstrated a consistent net clinical benefit across clinically relevant threshold probabilities.

CONCLUSION: UDFF provides accurate, independent, and clinically meaningful quantification of hepatic steatosis in tumor-related liver disease, and the population-specific cutoff values identified in this study may support improved preoperative evaluation and treatment planning.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Jiang, Qu, Jiang, et al. Diagnostic performance of ultrasound-derived fat fraction for detecting hepatic steatosis in patients with tumor-related liver disease. Abdom Radiol (NY). 2026. PMID: 42684475. doi:10.1007/s00261-026-05749-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。